PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: PD-1 inhibitor 200mg per three to four weeks, for one year Sponsors: Affiliated Hospital of Nantong University Recruiting

Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials